Work

Bevacizumab-IRDye800 Is an Effective Alternative to Anti-Carcinoembryonic Antigen (CEA) for Labeling Low CEA-Expressing Colorectal Tumors

Year: 2017

Type: article

Source: Journal of the American College of Surgeons

DOI: 10.1016/j.jamcollsurg.2017.07.067

Authors: Jonathan C. DeLong, Thinzar M. Lwin, Tasuku Kiyuna, Takashi Murakami, Gooitzen M. van Dam, Paul J. Yazaki, Bryan M. Clary, Robert M. Hoffman, Michael Bouvet

Institutions: University of California San Diego, AntiCancer (United States)

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2765642134

FWCI: 0.19

Cites:

Cited by: 1

Related to: 10